Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |